EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The Impact of Killer Cell Immunoglobulin‐Like Receptors and Human Leukocyte Antigen‐E, Human Leukocyte Antigen‐G Polymorphisms on Innate Immunity and COVID‐19 Severity

Cigdem Kekik iD, Sonay Temurhan iD, Yeliz Ogret iD, Behnoush Nasr Zanjani iD, Demet Kıvanc iD, Fatma Savran Oguz iD, Murat Kose iD, Fatma Betul Oktelik iD, Gunnur Deniz iD

Journal of Immunology Research · 2025

DOI: 10.1155/jimr/6691437 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Immunology Research, 2025. Verfasst von Cigdem Kekik und 8 weiteren Autor:innen. Beteiligte Einrichtung: Tissue Typing Laboratory, Department of Medical Biology, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Türkiye. Hauptthemen laut MEDLINE: COVID-19, Receptors, KIR, SARS-CoV-2, HLA-G Antigens. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) infection spans a spectrum of symptoms, ranging from mild respiratory issues to severe outcomes like pneumonia, acute respiratory distress syndrome, and fatality. Natural killer (NK) cells, governed by killer cell immunoglobulin‐like receptors (KIRs), play a pivotal role in directly combating viral infections. Emerging studies indicate a decline in NK cell numbers and heightened NKG2A expression in infected individuals.

Objective

This study focuses on genotyping human leukocyte antigen (HLA)‐E, HLA‐G, and KIR in SARS‐CoV‐2‐positive individuals, comparing data between those with mild and moderate/severe symptoms. The cohort comprised 100 COVID‐19‐positive patients and 100 healthy volunteers, both groups subjected to DNA isolation and genotyping using sequence‐based sequencing.

Results

In 97 COVID‐19‐positive patients (52 mild, 24 moderate, and 21 severe) and 100 healthy volunteers, the study revealed protective associations with inhibitory alleles (KIR2DL1, KIR2DL3, KIR2DL4, KIR3DL1, KIR3DL2, and pseudo‐alleles like KIR3DP1 ∗ 003). Conversely, predisposing factors included activator alleles (KIR2DS2, KIR3DS1) and pseudo‐alleles (KIR3DP ∗ 001/002). The G ∗ 01:04 allele and G ∗ 01:04‐G ∗ 01:04 genotype emerged as protective, while the HLA‐E ∗ 01:03‐HLA‐E ∗ 01:03 genotype may negatively impact disease prognosis. Conversely, the HLA‐E ∗ 01:01‐HLA‐E ∗ 01:03 and HLA‐E ∗ 01:01‐HLA‐E ∗ 01:01 genotypes may confer protection.

Conclusion

Genetic variations in KIR, HLA‐E, and HLA‐G are associated with susceptibility and resistance to severe COVID‐19 outcomes. This elucidates the intricate interplay of NK cells and immune‐related genes, offering insights into potential therapeutic avenues and personalized approaches.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19Receptors, KIRSARS-CoV-2HLA-G AntigensKiller Cells, NaturalHistocompatibility Antigens Class IHumansFemaleMaleImmunity, InnateMiddle AgedSeverity of Illness IndexAdultHLA-E AntigensAgedGenotypePolymorphism, GeneticAllelesGenetic Predisposition to Disease

Stichwörter der Autor:innen

COVID-19HLA-G genotypeHuman Leukocyte Antigen-E (HLA-E)killer cell immunoglobulin-like receptor (KIR)severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)

Substanzen

Receptors, KIRHLA-G AntigensHLA-E AntigensHistocompatibility Antigens Class I

Autor:innen und Institutionen

  • Tissue Typing Laboratory, Department of Medical Biology, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Türkiye.
  • Institute of Graduate Studies in Health Science, Istanbul University, Istanbul, Türkiye.
  • Department of Internal Medicine, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Türkiye.
  • Department of Immunology, Aziz Sancar Institute of Experimental Medicine, Istanbul University, Istanbul, Türkiye.

ORCID-Profile: Cigdem Kekik, Sonay Temurhan, Yeliz Ogret, Behnoush Nasr Zanjani, Demet Kıvanc, Fatma Savran Oguz, Murat Kose, Fatma Betul Oktelik, Gunnur Deniz

Zitieren

APA

Kekik, C., Temurhan, S., Ogret, Y., Zanjani, B. N., Kıvanc, D., Savran Oguz, F., Kose, M., Oktelik, F. B., & Deniz, G. (2025). The Impact of Killer Cell Immunoglobulin‐Like Receptors and Human Leukocyte Antigen‐E, Human Leukocyte Antigen‐G Polymorphisms on Innate Immunity and COVID‐19 Severity. Journal of Immunology Research. https://doi.org/10.1155/jimr/6691437

Vancouver

Kekik C, Temurhan S, Ogret Y, Zanjani BN, Kıvanc D, Savran Oguz F, et al. The Impact of Killer Cell Immunoglobulin‐Like Receptors and Human Leukocyte Antigen‐E, Human Leukocyte Antigen‐G Polymorphisms on Innate Immunity and COVID‐19 Severity. Journal of Immunology Research. 2025. doi:10.1155/jimr/6691437

BibTeX
@article{Kekik2025,
  author = {Kekik, Cigdem and Temurhan, Sonay and Ogret, Yeliz and Zanjani, Behnoush Nasr and Kıvanc, Demet and Savran Oguz, Fatma and Kose, Murat and Oktelik, Fatma Betul and Deniz, Gunnur},
  title = {The Impact of Killer Cell Immunoglobulin‐Like Receptors and Human Leukocyte Antigen‐E, Human Leukocyte Antigen‐G Polymorphisms on Innate Immunity and COVID‐19 Severity},
  journal = {Journal of Immunology Research},
  year = {2025},
  doi = {10.1155/jimr/6691437}
}
Kostenlos starten →